These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14971842)

  • 1. Are selective COX-2 inhibitors as effective as NSAIDs in patients with rheumatoid arthritis?
    Smucny J; Chai G
    Am Fam Physician; 2004 Feb; 69(3):595-6. PubMed ID: 14971842
    [No Abstract]   [Full Text] [Related]  

  • 2. An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference.
    Tannenbaum H; Peloso PM; Russell AS; Marlow B
    Can J Clin Pharmacol; 2000; 7 Suppl A():4A-16A. PubMed ID: 11011110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition].
    MMW Fortschr Med; 2002 Jul; 144(29-30):52. PubMed ID: 12219613
    [No Abstract]   [Full Text] [Related]  

  • 4. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs.
    Jüni P; Dieppe P
    Age Ageing; 2004 Mar; 33(2):100-4. PubMed ID: 14960422
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversies in COX-2 selective inhibition.
    Simon LS; Smolen JS; Abramson SB; Appel G; Bombardier C; Brater DC; Breedveld FC; Brune K; Burmester GR; Crofford LJ; Dougados M; DuBois RN; Fitzgerald GA; Frishman W; García Rodríguez LA; Hochberg MC; Kalden JR; Laine L; Langman MJ; Prescott SM; van de Putte LB; Whelton A; White WB; Willaims GH
    J Rheumatol; 2002 Jul; 29(7):1501-10. PubMed ID: 12136912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective COX 2 inhibitor rofecoxib. To "defy" the pain].
    MMW Fortschr Med; 2003 Aug; 145(31-32):56-7. PubMed ID: 14524083
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rofecoxib: its efficacy in rheumatoid arthritis and acute pain].
    Morović-Vergles J
    Reumatizam; 2003; 50(2):47-8. PubMed ID: 15098376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New therapeutic approaches. 1. Non-steroidal anti-inflammatory agents and selective COX-inhibition].
    Sano H
    Nihon Naika Gakkai Zasshi; 2000 Oct; 89(10):2128-37. PubMed ID: 11215128
    [No Abstract]   [Full Text] [Related]  

  • 10. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is there a future for COX-2 inhibitors?].
    Yodfat Y
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 13. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening patients on long term non-steroidal anti-inflammatory drugs (NSAIDs) for nephrotoxicity--why necessary and how frequently?
    Chogle AR
    J Assoc Physicians India; 2003 Nov; 51():1041-2. PubMed ID: 15260384
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alleviating pain and preventing inflammation with selective COX-2 inhibitors. Prescribing with confidence in the future].
    MMW Fortschr Med; 2005 Mar; 147(9):12. PubMed ID: 15794346
    [No Abstract]   [Full Text] [Related]  

  • 17. Rofecoxib: a new selective COX-2 inhibitor.
    Rajadhyaksha VD; Dahanukar SA
    J Postgrad Med; 2001; 47(1):77-8. PubMed ID: 11590304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 19. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID alternatives.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):8. PubMed ID: 15647706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.